AbbVie and Apogee Could Be a Perfect Match. Other Strategics May Also Be Interested; Estimates Under Review.

Research evidence excerpt

AbbVie and Apogee Could Be a Perfect Match. Other Strategics May Also Be Interested; Estimates Under Review.

Artificial intelligence tools may have been used in the preparation of this material, including assisting in fact-finding, data analysis,

pattern recognition, and content drafting.

BTIG reports are based on public information and BTIG considers the same to be reliable, comprehensive information, but

makes no representation or warranty that the reports are accurate or complete. BTIG opinions and information provided in

this report are as of the date of the report and may change without notice. An issuer may be classified as “Under Review” or

“Research Restricted”. In these cases, investors should consider any previous investment recommendation and/or rating to a

subject company/issuer to no longer be current and should not be relied upon nor considered a solicitation.

This research report is not an offer to buy or sell or solicitation of an offer to buy or sell any security in any jurisdiction where suchBIOTECHNOLOGY an offer or solicitation would be illegal. This research report was not drafted specifically for any particular individual or entity and

is not a personal recommendation to participate in any particular trading strategy or transaction. Any recipient of this research

report should obtain independent advice specific to their personal circumstances before undertaking any investment activity and

must make their own independent evaluation of any securities or financial instruments.EQUITY Facts, views or opinions presented in this report have not been reviewed by, and may not reflect information known to, employees

or other professionals in the “BTIG Group” (BTIG Group includes, but is not limited to, BTIG and its parents, subsidiaries and/

or affiliates).